Zimmer Biomet Announces Board and Executive Changes
Ticker: ZBH · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1136869
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: ZBH
TL;DR
Zimmer Biomet shakes up board, exec pay on June 20th.
AI Summary
Zimmer Biomet Holdings, Inc. announced on June 20, 2024, changes in its board of directors and executive compensation. Specifically, the company elected new directors and appointed new officers, alongside adjustments to their compensatory arrangements. The filing also includes information regarding financial statements and exhibits, as well as a Regulation FD disclosure.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial distress or significant operational changes indicated.
Key Players & Entities
- ZIMMER BIOMET HOLDINGS, INC. (company) — Registrant
- June 20, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but specific names and details of the changes are not provided in this summary section.
Were there any new executive appointments?
Yes, the filing mentions the appointment of certain officers.
What is the nature of the compensatory arrangements mentioned?
The filing refers to compensatory arrangements of certain officers, but the specifics are not detailed in this overview.
What is the company's state of incorporation?
Zimmer Biomet Holdings, Inc. is incorporated in Delaware.
What is the fiscal year end for Zimmer Biomet?
The fiscal year end for Zimmer Biomet Holdings, Inc. is December 31st.
Filing Stats: 787 words · 3 min read · ~3 pages · Grade level 11 · Accepted 2024-06-20 07:30:11
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value ZBH New York Stock Exchan
Filing Documents
- zbh-20240620.htm (8-K) — 50KB
- zbh-ex99_1.htm (EX-99.1) — 17KB
- img210921253_0.jpg (GRAPHIC) — 39KB
- 0000950170-24-075310.txt ( ) — 402KB
- zbh-20240620.xsd (EX-101.SCH) — 134KB
- zbh-20240620_htm.xml (XML) — 7KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. A copy of the Company's press release related to the matters discussed in this Form 8-K is attached hereto as Exhibit 99.1. The information contained in this Item 7.01 and Exhibit 99.1 hereto is being furnished and shall not be deemed to be "filed" with the Securities and Exchange Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 10.1 Form of Indemnification Agreement with Non-Employee Directors and Officers (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed July 31, 2008) 99.1 Press Release issued by Zimmer Biomet Holdings, Inc., dated June 20, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 20, 2024 ZIMMER BIOMET HOLDINGS, INC. By: /s/ Chad F. Phipps Name: Chad F. Phipps Title: Senior Vice President, General Counsel and Secretary